Search research articles
Contact Us
Filters
Showing results (241-250 of 311) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Lori J Wirth, Marcia S Brose, Eric J Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2009
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]
J Simon W Stewart, Ezra E W Cohen, Lisa Licitra, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma
Emily Ho, Loris De Cecco, Stefano Cavalieri, et al.
Oral Oncology
|
October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
Stefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
The Laryngoscope
|
August 2, 2019
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach
Ester Orlandi, Stefano Cavalieri, Roberta Granata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2019
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
Robert L Ferris, Lisa Licitra, Jerome Fayette, et al.
Cancers
|
April 15, 2020
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
Salvatore Alfieri, Andrea Carenzo, Francesca Platini, et al.
The Lancet. Oncology
|
May 19, 2015
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
Nicole Basset-Seguin, Axel Hauschild, Jean-Jacques Grob, et al.
The Lancet. Oncology
|
June 11, 2013
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B Vermorken, Jan Stöhlmacher-Williams, Irina Davidenko, et al.
Future Oncology (London, England)
|
March 28, 2023
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)
Stefano Cavalieri, Viviana Vitolo, Amelia Barcellini, et al.
Page
of 32
Search research articles
Search
Showing results (241-250 of 311) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Lori J Wirth, Marcia S Brose, Eric J Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2009
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]
J Simon W Stewart, Ezra E W Cohen, Lisa Licitra, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma
Emily Ho, Loris De Cecco, Stefano Cavalieri, et al.
Oral Oncology
|
October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
Stefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
The Laryngoscope
|
August 2, 2019
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach
Ester Orlandi, Stefano Cavalieri, Roberta Granata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2019
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
Robert L Ferris, Lisa Licitra, Jerome Fayette, et al.
Cancers
|
April 15, 2020
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
Salvatore Alfieri, Andrea Carenzo, Francesca Platini, et al.
The Lancet. Oncology
|
May 19, 2015
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
Nicole Basset-Seguin, Axel Hauschild, Jean-Jacques Grob, et al.
The Lancet. Oncology
|
June 11, 2013
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B Vermorken, Jan Stöhlmacher-Williams, Irina Davidenko, et al.
Future Oncology (London, England)
|
March 28, 2023
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)
Stefano Cavalieri, Viviana Vitolo, Amelia Barcellini, et al.
Page
of 32